Netflix (NFLX)
Verdict history · NFLX
Every call Verdix has made on NFLX.
While a verdict holds, its return keeps accumulating from the day the call was made — it resets only when the verdict itself changes.
Click any date below to read that write-up
The prior article's SELL trigger — a break below $75.01 — fired when NFLX traded to $74.79 on heavy insider-selling volume, and that alone flips WAIT to SELL regardless of the panel's split. This time, however, the panel lands on SELL independently: the removal of The Activist Catalyst and the addition of The Asymmetric Bargainer produces zero bullish voices, and even the two Neutral archetypes are buyers only at lower prices. The price clawed back to $79.59 but remains trapped below the weekly EMA20 at $80.55, meaning the downtrend is intact and the cluster insider signal has only deepened since the last article.
See methodology for how verdicts are produced. Full track record →
The panel’s case against NFLX — and where they disagree.
The case against outweighs the case for at today's price.
NASDAQ · Communication Services · 2026-08-22 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
SellMEDIUM confidence
Why
Netflix's business is excellent — 49.5% ROE, $11.2B in free cash flow, a wide moat — but the panel is unanimous in caution after both Co-CEOs and the CFO sold stock in a tight August cluster at $73–$76, the technical trend remains bearish below $80.55, and earnings estimates are drifting down. All six voices land Bearish or Neutral, with the Neutrals waiting for a pullback into the $65–70 range before seeing a margin of safety. The question is whether the insider selling signals real trouble ahead or whether the ad-revenue ramp will prove them wrong before the stock breaks below $75 support.Level to watch
Key resistance 80.55+1.2% from 79.59
Next catalyst
Trigger to confirm the breakdown: A weekly close below $75.00 — the monthly 50% Fibonacci retracement and the horizontal accumulation zone — would confirm the Stage 4 thesis and likely open a path to $69.72, the next structural support.The panel's take
Verdict: SELL · Conviction: MEDIUM · Last price: 79.59 · Changed from WAIT
Panel: 0 Bullish · 2 Neutral · 4 Bearish → SELL
What changed since 2026-08-15:
- Price: 78.16 → 79.59 (+1.83%)
- Panel: 2 of 6 → 0 of 6 now Bullish — composition also changed: added The Asymmetric Bargainer; removed The Activist Catalyst
- Trigger: A weekly close above $80.55 (the weekly EMA20) with conviction volume would signal the intermediate downtrend is arrested — that reclaim would be the first piece of evidence the Stage 3/4 thesis is wrong. Alternatively, a pullback into the $65–70 range would bring price below The Intrinsic-Value Modeler's base case and into the margin-of-safety zone The Moat Compounder and The Asymmetric Bargainer require, flipping to BUY for the fundamental case alone.
- Verdict: WAIT → SELL
The prior article's SELL trigger — a break below $75.01 — fired when NFLX traded to $74.79 on heavy insider-selling volume, and that alone flips WAIT to SELL regardless of the panel's split. This time, however, the panel lands on SELL independently: the removal of The Activist Catalyst and the addition of The Asymmetric Bargainer produces zero bullish voices, and even the two Neutral archetypes are buyers only at lower prices. The price clawed back to $79.59 but remains trapped below the weekly EMA20 at $80.55, meaning the downtrend is intact and the cluster insider signal has only deepened since the last article.
The prior article's SELL trigger — a break below $75.01 — fired on 2026-08-11 when NFLX traded to $74.79 on heavy insider-selling volume. That alone flips WAIT to SELL regardless of the panel's current split, but the split also lands here independently: four of six voices are Bearish (The Intrinsic-Value Modeler, The GARP Operator, The Forensic Skeptic, The Scuttlebutt Growth Investor), and the two Neutrals (The Moat Compounder, The Asymmetric Bargainer) are buyers only at lower prices, not today. The verdict is SELL because the stock broke the line the last article said would confirm a Stage 4 decline, and the panel finds no reason to override it at $79.59 — consensus targets 17% higher sit behind a deteriorating technical trend, falling estimates, and a cluster insider-sell signal that the fundamental scouts agree is a red flag.
Key levels
Key levels · NFLX
USD · as of 2026-08-22Analyst consensus target 93.42 USD · range 70–135
Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
Key resistance begins just above price at the weekly EMA20 ($80.55), the first level the stock must reclaim to challenge the bearish intermediate trend. The $88.65–89.22 cluster is the real barrier — weekly EMA50 and monthly EMA20 converged with the monthly 38.2% Fibonacci retracement, a zone price broke down from in July and has not tested since. Key support sits at $75.01–75.19, the monthly 50% Fibonacci retracement and horizontal support that was breached intra-week on 2026-08-11 but has not yet closed below on a weekly basis; a confirmed break opens the path to the weekly EMA200 at $72.87. The analyst consensus target of $93–94 sits well above resistance, reflecting a fundamental view at odds with the technical reality — 17% upside that requires the stock to first repair the damage it has sustained.
What legendary investors think
We ran Netflix past a panel of 6 legendary investors' frameworks.
The panel · 6 investors
The GARP OperatorGrowth (GARP)🔴 BearishMed
Signal: PEG sits at 1.08 — exactly the fair-value line — and with both Co-CEOs and the CFO unloading shares at $73–$76 in a one-week August cluster, the ratio gives no margin for error while insiders are voting with their feet. Conviction: Conviction is held back because the advertising story, however real, is not a near-term catalyst, and the gap between a PEG of 1.08 and the PEG of 0.85 that existed at $65 leaves no cushion if the estimate-revision drift continues.
The Intrinsic-Value ModelerValuation/DCF🔴 BearishMed
Signal: My base-case DCF lands at $70.66 against a $79.59 price, and the cluster insider selling by both Co-CEOs and the CFO at $73–$76 makes it difficult to argue the market is mispricing the stock to the downside. Conviction: Conviction is restrained by the tight range between bear and bull cases: the bear scenario drops to $55.20 on a 10% WACC, while the bull case of $92.40 needs both a lower discount rate and margin expansion, leaving the base case with a thin margin of safety.
The Forensic SkepticContrarian/Forensic🔴 BearishLow
Signal: Net asset value sits at $7.24 per share and the entire equity cushion above that rests on future growth priced at 25x trailing earnings, so when both co-CEOs and the CFO sell into weakness at $73–$76, the people with the best information are signaling the growth premium is not supported. Conviction: Confidence is capped because the market is not panicked — VIX at 14 and RSI at 45.6 means no forced selling exists to exploit — and without panic, a contrarian long needs a fundamental catalyst that remains absent.
The Moat CompounderValue/Quality/Moat⚫ NeutralMed
Signal: Return on equity of 49.5% and $11.2 billion in trailing free cash flow confirm this is a wonderful business, but the concurrent insider sales by both Co-CEOs and the CFO within a single week at prices below today's level introduce a governance question I cannot ignore. Conviction: My willingness to commit capital is restrained because, at 25x earnings with a PEG near 1.0, the price offers fair value rather than the bargain I insist on, and the insider cluster undermines the conviction that management sees the same long-term value I do.
The Asymmetric BargainerContrarian/Deep Value⚫ NeutralMed
Signal: The Dhandho framework fails on the downside-protection test because at 25x trailing earnings the stock carries a plausible 20–30% drawdown risk if subscriber growth stalls or ad revenue disappoints, a risk the August insider-selling cluster only amplifies. Conviction: The expected-value math tilts positive at roughly +15.5%, but conviction is held back because the payoff distribution is too symmetrical — the odds of a 25% loss roughly offset the odds of a 50% gain — and a concentrated bet demands clearer asymmetry.
The Scuttlebutt Growth InvestorGrowth/Management🔴 BearishLow
Signal: The 15-point checklist scores only 5 of 15 criteria as clear passes, and 12 criteria — including management candor, integrity, R&D effectiveness, and labor relations — lack sufficient evidence, while both Co-CEOs and the CFO sold stock in the same week at depressed prices, directly challenging criteria 14 and 15. Conviction: Conviction is held back because the Scuttlebutt Growth Investor-style analysis cannot be completed when three-quarters of the checklist goes unanswered, and the insider cluster strikes at the two criteria — candor and integrity — that The Scuttlebutt Growth Investor considered non-negotiable for any holding.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- The business itself is excellent: 49.5% ROE, roughly 28–30% operating margins, $11.2B in trailing FCF, and a wide moat built on 280M+ subscribers and a proprietary content library.
- The concurrent insider sales by both Co-CEOs and the CFO at $73–$76 in early August 2026 are a red flag that every voice on the panel acknowledges, even if they weight it differently.
- The technical picture is deteriorating: price sits below the weekly EMA20 ($80.55) and EMA50 ($88.65), the weekly EMAs are bearish-crossed, and the monthly EMA20 has been breached.
- Earnings estimates are being revised downward with roughly two downgrades for every upgrade over the last 30 days, and the quarterly beat rate is mixed at best.
- The advertising revenue story is real but unproven at scale, and no archetype treats it as a near-term catalyst that overrides the bearish signals.
The real debate
- The Moat Compounder sees a wonderful business at a fair price worth holding but not buying, while The Intrinsic-Value Modeler sees a stock already priced above base-case value — the debate is whether 25x earnings is fair or slightly rich for a decelerating growth story.
- The Asymmetric Bargainer calculates a +15.5% expected return but rejects it for lacking asymmetry, while The GARP Operator sees a PEG of 1.08 and concludes it is a coin flip — both agree the setup is not compelling, but they arrive there through different frameworks.
- The Forensic Skeptic argues the asset-based floor is irrelevant at $7.24 per share and the entire valuation rests on growth assumptions insiders are implicitly doubting, while The Scuttlebutt Growth Investor argues the qualitative picture is too incomplete to render any verdict with high confidence.
The question it comes down to: Does the August 2026 insider-selling cluster by both Co-CEOs and the CFO represent a genuine signal about forward fundamentals, or is it a coincidental 10b5-1 scheduling artifact that the market is overreading — and can the ad-revenue ramp prove the insiders wrong before the technical trend breaks support at $75?
The bottom line
- Trigger to confirm the breakdown: A weekly close below $75.00 — the monthly 50% Fibonacci retracement and the horizontal accumulation zone — would confirm the Stage 4 thesis and likely open a path to $69.72, the next structural support.
- Trigger to reverse the call: A weekly close above $80.55, the weekly EMA20, on conviction volume — defined as at least 1.5x the 20-week average — would signal the intermediate downtrend is arrested and force a reassessment of the bearish verdict.
- Next catalyst: Q3 2026 earnings in mid-October, with consensus EPS of $0.82: a miss would validate the estimate-revision drift and insider caution, while a clean beat paired with raised guidance could begin reversing the negative sentiment cycle.
- Risk to monitor: Any further insider sales by Peters, Sarandos, or Neumann after the August cluster would compound the red flag, especially if executed at prices below $80; conversely, any insider open-market purchase by the same executives would be a powerful bullish signal.
- Further out: If ad revenue scales to the $3 billion annual run-rate target and the cannibalization fear proves unfounded, the estimate-revision trend should flip from downgrades to upgrades, which would alter the growth trajectory that every valuation model on this panel currently discounts.
contact@verdixhq.com · Published 2026-08-22 · Prices as of 2026-08-22 · Time horizon: 3–12 months · No direct position held in NFLX · NFLX verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
The panel also debated